A partnership has been reached by Senseonics, Roche Diabetes Care and TypeZero Technologies to create an automated insulin delivery system through the integration of Senseonic's Eversense glucose monitor, TypeZero's inControl AP algorithms and Roche's Accu-Chek Insight insulin pump. The collaboration comes as part of an NIH-funded trial of artificial pancreas systems.